Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1613 1646 1655
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18775416 | POROUS MEDICAL DEVICE AND METHODS OF USE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18984644 | PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE | Non-Final OA | ANTECIP BIOVENTURES II LLC |
| 18517448 | ANTI-TUMOR AGENT | Non-Final OA | FUJIFILM Corporation |
| 18870231 | HERBICIDAL DERIVATIVES | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18684750 | HERBICIDAL MALONAMIDES | Non-Final OA | BASF SE |
| 18572884 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | Final Rejection | The Regents of the University of Michigan |
| 18802080 | SOLVENT-BASED DETERGENT COMPOSITIONS AND METHODS FOR HYDROPHOBIC SOIL REMOVAL | Non-Final OA | ECOLAB USA INC. |
| 18536437 | DISSOLVABLE POLYMERIC EYE INSERTS | Final Rejection | Alcon Inc. |
| 18169695 | HEMOSTATIC NANOPARTICLES FOR THE TREATMENT OF NON-COMPRESSIBLE HEMORRHAGE AND INTERNAL BLEEDING | Non-Final OA | The General Hospital Corporation |
| 18503969 | USE OF MICRORNA-146A AND NANOCERIA CONJUGATE TO IMPROVE WOUND HEALING AND PROMOTE TISSUE REGENERATION | Final Rejection | The Trustees of the University of Pennsylvania |
| 18594760 | Oral Care Compositions and Methods of Use | Final Rejection | Colgate-Palmolive Company |
| 18642331 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | Final Rejection | Senseonics, Incorporated |
| 18800641 | COMPOSITIONS AND METHODS FOR TREATING DENTIN CARIES | Non-Final OA | Rutgers, The State University of New Jersey |
| 18928222 | INJECTABLE ANTI-HEART FAILURE HYDROGEL WITH MYOCARDIAL TISSUE REPAIR FUNCTION, PREPARATION METHOD AND USE THEREOF | Non-Final OA | SICHUAN UNIVERSITY |
| 18847701 | HAIR CONDITIONER FORMULATION | Non-Final OA | Dow Silicones Corporation |
| 18736036 | COSMETIC COMPOSITIONS | Non-Final OA | MARY KAY INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy